# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
ATRenew (NYSE:RERE) sees Q3 sales of $704.953 million-$718.912 million vs $725.000 million analyst estimate.
ATRenew (NYSE:RERE) reported quarterly earnings of $0.09 per share which beat the analyst consensus estimate of $0.04 by 125 pe...